Dietary Reporting in the Amyloidoses

Launched by BARBARA ANN KARMANOS CANCER INSTITUTE · Feb 17, 2023

Keywords

ClinConnect Summary

This clinical trial, called "Dietary Reporting In The Amyloidoses," aims to understand how malnutrition and weight loss affect patients with amyloidosis, a condition where an abnormal protein builds up in the body. The researchers want to find out if using a smartphone app called MyFitnessPal can help gather detailed information about what patients eat and drink, including any vitamins or herbal supplements they might take.

To participate, you need to be 18 years or older, have a diagnosis of amyloidosis, and be comfortable using the MyFitnessPal app on your phone. If you join the study, you'll first complete a questionnaire, then download the app and follow a tutorial. For about eight weeks, you'll track your daily food and supplement intake using the app. You'll also fill out more questionnaires after two weeks and at the end of the study. This trial is currently looking for participants, so if you're interested, it could be a great opportunity to help advance knowledge about dietary habits in amyloidosis patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age or older
• • Diagnosed with any type of amyloidosis
• • Speak, read and write in English
• • Willing to use the MyFitnessPal app on their own smartphone
• Exclusion Criteria:
• • a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
• • cognitive or perceptual disturbances